We previously identified a microdeletion (Del) in the maternally imprinted PEG3 domain in cattle that results in loss of paternal MIMT1 expression and causes late-term abortion and stillbirth. The mutation, when inherited from the sire, is semilethal for his progeny, with 85% mortality. Here we precisely delineate the deletion and describe comparative analyses of fetuses carrying the deletion with wild-type (WT) siblings. Global DNA methylation analysis of cotyledon tissue revealed greater global CpG methylation in fetuses with the deletion (P ¼ 0.003). Gene expression microarray analyses identified increased NPSR1A, IL1RN, NOS3, IL4R, ZDHHC22, and SMOC2 expression in fetuses carrying the deletion and decreased GRID1, PLG, and IGF1 expression. Involvement of the NPSR1A, IL1RN, NOS3, and IL4R genes suggests that some form of restriction related to blood supply, perhaps hypoxemia, may play a role in the pathological mechanism. Also, imprinted genes known to play a role in mammalian prenatal development, specifically IGF2, DLK1, MEST, AST1, PEG3, APEG3, and H19, showed differential expression. The most striking difference was abundant abnormal expression of the neuropeptide S receptor 1 (NPSR1) gene in placental cotyledon tissue of 7 of 11 MIMT1 Del/WT fetuses. The similarity of this proportion to that of the semilethal mortality rate suggests that abnormal NPSR1 expression may be linked to death or survival of MIMT1 Del/WT
INTRODUCTION
Stillbirth is a common adverse pregnancy outcome in humans and livestock. Despite recent advances in prenatal diagnosis, 1 in every 200 women who reaches her 24th week of pregnancy will have a stillborn baby. Among livestock species, stillbirth is recorded mainly in dairy cattle and is a functional trait that is important from both an economic and an animal welfare standpoint. For example, in U.S. Holstein cattle, ;7% of all calves are stillborn [1] .
External influences such as environment, animal management, or disease affect prenatal mortality, but genetic factors are also important. Fetal growth is highly correlated with the incidence of dystocia and stillbirth [2] , and the genetic heritability (h 2 ) of fetal growth is relatively high (0.2-0.6) in cattle [2] . Imprinted genes, which are exclusively expressed from one parental chromosome, play a leading role in controlling fetal growth. Consistent with the growth phenotypes observed, many mammalian imprinted genes are known to be expressed in placenta [3] and are critical for fetal survival [4] . Placental function is clearly fundamental for fetal growth, and imprinted genes expressed in the placenta have been implicated in fetal growth disorders and resource acquisition [5] .
We previously identified and approximately localized a microdeletion that truncated the 3 0 end of the MER1 repeat containing imprinted transcript 1 (MIMT1) gene, causing late abortions and stillbirths in cattle [6] . Stillborn calves were undersized by ;50% and had uninflated lungs but were otherwise phenotypically normal. Analysis of the bovine genome assembly (Btau4.2) and comparison with corresponding regions in other species confirmed that MIMT1 could be the only causative gene in the locus. The deletion, when inherited from the sire, is semilethal for his progeny, with an observed mortality rate of 85%. Why the other 15% of progeny survive is unclear. Here we describe precise localization of the deletion and its functional consequences in terms of DNA methylation and altered gene expression.
MIMT1 is a nonprotein-coding gene that forms part of the imprinted paternally expressed gene 3 (PEG3) domain. The PEG3 domain consists of seven genes clustered in a 500-kb genomic region on human chromosome 19 and cattle chromosome 18, and six genes on mouse chromosome 7. Most PEG3 domain genes are expressed during embryogenesis and in adult ovary, testis, and brain [7, 8] . Peg3 is the gene most studied in the PEG3 domain and is known to be involved in control of prenatal growth and development [9] , maternal nurturing behavior in mice [9] , and regulation of metabolism and body fat [10] . It is also thought to play an important role in healthy pregnancy and resource acquisition by the fetus [11] . In mice, heterozygous progeny that inherit a Peg3 null allele from their male parent are undersized but otherwise phenotypically normal [9] .
Because placental dysfunction is a primary cause of growth retardation, we therefore studied gene expression and DNA methylation levels in placental tissues of fetuses carrying the deletion (referred to as MIMT1 Del/WT ) and those carrying the wild-type gene (MIMT1 WT/WT ). Here we show that a group of genes associated with fetal/placental circulation may indicate problems with pregnancy. In particular, we describe abnormal placental expression of the neuropeptide S receptor 1 (NPSR1) gene.
MATERIALS AND METHODS

Ethics Statement
Blood sampling and insemination were carried out using standard veterinary protocols according to the European Union Normative for Care and Use of Experimental Animals. All animal experiments were approved by the Animal Ethics Committee of the State Provincial Office of Southern Finland (ESAVI-2010-08583/YM-23).
Animals and Tissue Sampling
For deletion screening, 9-ml blood samples were collected from the jugular veins of 79 animals and stored in EDTA tubes. Cows scheduled for slaughter were inseminated with semen from the YN51 bull in which the deletion was first identified [6] .
The microarray expression study was performed with 10 fetal cotyledon samples (4 MIMT1 WT/WT and 6 MIMT1 Del/WT samples). For quantitative realtime RT-PCR (RT-qPCR) expression and DNA methylation studies, brain, cotyledon (placental structure on the fetal side) and caruncle (maternal side) tissue samples were collected from 22 fetuses (11 MIMT1 Del/WT and 11
MIMT1
WT/WT fetuses). Fetuses were collected between 41 and 157 days of pregnancy. Samples were immediately frozen in liquid nitrogen and stored at À808C for further analyses. For the NPSR1 isoform A expression study, fetal lung, kidney, heart, liver, and muscle samples were collected.
DNA and RNA Extraction
Genomic DNA was extracted from blood by using the Magnetic Separation Module I (Chemagen). Genomic DNA and total RNA from tissue samples were extracted using DNA and RNeasy mini-kits (QIAamp and Qiagen, respectively). All extractions were carried out according to the manufacturers' instructions.
Histology
The cotyledon (pars fetalis) and caruncula (pars maternalis) were separated from each other by light traction. Tissue samples were subjected to standard formalin fixation and embedded in paraffin. Sections (5 lm) were cut and stained with hematoxylin-eosin stain.
Screening of the Deletion Borders and Deletion Test
Primers are listed in Supplemental Table S1 (all supplemental data are available online at www.biolreprod.org). All primers were designed using Primer3 software (http://frodo.wi.mit.edu/primer3/). Single nucleotide polymorphism genotypes of YN51 and samples C1-C11 were determined by comparative sequencing. PCR conditions were 3 mM MgCl 2 in 13 buffer (Green GoTaq reaction buffer; Promega), 5 mM of each dNTP, 10 pM of each primer, 5 U of GoTaq polymerase (Promega), and 100 ng of genomic DNA. Thermal cycling conditions consisted of initial denaturation at 958C for 5 min; denaturation at 958C for 40 sec; annealing at 588-648C for 40 sec; elongation at 728C for 1 min; repeated in 35 cycles; and then a final elongation at 728C for 2 min. PCR product size was confirmed by 1.5 % agarose gel electrophoresis and purified for sequencing reaction with 4 U of exonuclease I (Fermentas) and 1 U of shrimp alkaline phosphatase (Fermentas) according to the manufacturer's instructions. Sequencing was carried out with a 3730xl model DNA analyzer (Applied Biosystems). All sequences were analyzed with Sequence Scanner version 1.0 software (Applied Biosystems) and T-Coffee software (multiple sequence alignment; http://www.ebi.ac.uk/Tools/msa/tcoffee/). The breakpoints of the deletion were identified with the BLAST search tool (http://genome.ucsc. edu/cgi-bin/hgBlat?command¼start).
For deletion testing, PCR was performed using a primer pair that spanned the deletion breakpoints (Supplemental Table S1 ). PCR product size was confirmed by 2% agarose gel electrophoresis. In each PCR assay, samples YN51, C5, C6, and C9 were used as positive controls, and C2, C7, C10, and C11 were used as negative controls. All samples were also tested with a control primer pair located outside the deletion in the PEG3 domain to ensure DNA quality.
Luminometric Methylation Assay
Global DNA methylation was quantified using luminometric methylation assay as previously described [12] . Briefly, 1 lg of genomic DNA was cleaved with isoschizomer restriction enzymes HpaII plus EcoRI or with MspI plus EcoRI (FastDigest; Fermentas) in two separate reaction mixtures for 20 min. Digestions were performed in a 24-well format using a PyroMark Q24 system (Qiagen). Luminometric peaks were calculated with PyroMark Q24 software. The HpaII:EcoRI and MspI:EcoRI ratios were calculated as [dGTP þ dCTP]/ aATP for their respective reactions. DNA methylation was calculated from the HpaII:MspI ratio, where a ratio of 1 indicates 0% methylation and a ratio approaching 0 corresponds to 100% DNA methylation at the CCGG sites investigated.
Microarray Analysis
Total RNA was isolated from 10 fetal samples (4 MIMT1 WT/WT and 6
MIMT1
Del/WT samples) using Trizol reagent (Invitrogen) according to the manufacturer's instructions. Quantity and purity of RNA were measured with NanoDrop 1000 (Peqlab Biotechnologie). Microarray analysis was performed using 8 3 60 k bovine SurePrint G3 custom gene expression arrays (AMADID 031042; Agilent). The design of this array was based on the Gene Expression Microarray (AMADID 023647; Agilent) and additional transcripts from Entrez Gene (October 2010) and Ensembl59, which were probably not represented on the Agilent catalog array. Cy3-labeled cRNA was produced with Low-Input Quick Amp labeling kit, one-color (Agilent), and hybridized to the microarrays according the manufacturer's instructions. Hybridized and washed slides were scanned at 2-lm resolution with a DNA microarray scanner (G2505C model; Agilent). Image processing was performed with Feature Extraction software version 10.7.3.1 (Agilent). Processed signals were filtered based on ''Well above background'' flags, that is, detection in three of four or four of six samples in either of the two experimental groups, and normalized with BioConductor software VSN (variance-stabilizing normalization) [13] . For quality control, normalized data were analyzed with a distance matrix and a heat map based on pairwise correlation of the samples (gene plotter software; BioConductor ). Significance analysis was performed using Limma software (BioConductor) [14] . Method of false discovery rate was used for correction of multiple testing.
Quantitative Real-Time RT-PCR
A total of 22 RNA samples, including those for microarray analysis, were used for RT-qPCR. Total RNA was extracted using Trizol reagent (Invitrogen) according to the manufacturer's protocol, with some modifications. After DNase I treatment (Fermentas), RNA was quantified using a NanoDrop model ND-1000 (PeqLab) spectrophotometer, and RNA integrity was determined by denaturing EtBr 1% agarose gel electrophoresis. Complementary DNA (cDNA) was synthesized using a First-Strand cDNA synthesis kit (Fermentas). Twostep qPCR experiments were performed using Fast SybrGreen MasterMix (Applied Biosystems) and run on an ABI7500 machine (Applied Biosystems). Primer specificity and capture temperatures were determined by melting curve analysis. The threshold cycle (CT) number required to achieve a definite SYBR green fluorescence signal was calculated by the second derivative maximum method. The CT is correlated inversely with the logarithm of the initial template concentration. The relative expression difference between the MIMT1 Del/WT and MIMT1 WT/WT gene was calculated for each animal (DDCT). All cDNA samples were assayed in triplicate, and relative expression levels were normalized to endogenous GAPDH expression.
NPSR1 Expression Analysis
NPSR1 expression analysis was performed with brain, cotyledon, and caruncle samples collected from 22 fetuses. NPSR1 mRNA abundance was measured by RT-PCR using primers 1F and 1R, which hybridize to exons 4 and FLISIKOWSKI ET AL. exon 5 and amplify a 186-bp product. PCR was performed in 20-ll reaction volumes containing diluted first-strand cDNA equivalent to 50-ng input RNA. PCR products were loaded on 2% agarose gels to compare band intensities from MIMT1 Del/WT with those from MIMT1 WT/WT fetuses. GAPDH mRNA was amplified as an endogenous control. NPSR1 isoform A-specific RT-PCR was performed using primer 1F (exon 4) and 2R (exon 9).
Western Blot Analysis
Bovine tissue lysates from cotyledon and adult brain samples were obtained by mechanical homogenization of frozen tissue in mammalian cell lysis buffer (Sigma). Protein was quantified using advanced protein assay reagent (Cytoskeleton Inc.). A total of 10-40 lg of total protein was loaded in each lane and separated by 12% SDS-PAGE and electroblotted onto polyvinylidene fluoride membranes (Immobilon-P; Millipore). Membranes were blocked with 5% milk, incubated overnight at 48C with the primary antibody anti-NPSR1 (1:500 dilution; Sigma) and anti-GAPDH (1:5000 dilution; Sigma) and then for 1 h at room temperature with the horseradish-peroxidase-labeled secondary antibody anti-rabbit (1:5000 dilution; Sigma) and anti-mouse immunoglobulin G (IgG; 1:6000 dilution; Abcam). Chemiluminescence was detected with ECL Western blotting substrate kit (Pierce) using x-ray film (Agfa).
RESULTS
Characterization of the Microdeletion
We used serial direct sequencing to identify genomic breakpoints of the microdeletion in MIMT1
Del/WT fetuses and identified a 128 225-bp region deleted in the PEG3 domain on bovine chromosome 18 (BTA18), between base pairs 64 320 684 and 64 448 909 (based on University of Maryland version 3.1 of the bovine genome assembly). The deletion eliminates the 3 0 end (exons 3 and 4) of the noncoding MIMT1 gene and part of the intergenic region between the MIMT1 and USP29 genes. In mice, these genes (termed Ocat and Usp29, respectively) are transcribed as a single mRNA transcript but are transcribed in humans and cattle as two separate transcripts. The recent version of the bovine genome assembly (Btau4.2) together with a comparative map of corresponding regions in other species indicates that only the 3 0 end exons of MIMT1 lie within the deleted region. The rest of the deleted BTA18 region contains several repetitive elements such as retrotransposons, long terminal repeats, and tandem repeats.
PCR Test to Identify MIMT1
Del/WT Carriers Unfortunately, the MIMT1 Del allele has been bred extensively into the Finnish national herd. We used the sequence data to develop a simple, robust screen to identify affected animals by PCR amplification across deletion breakpoints. This markedly improves on the preliminary screen based on DNA copy number described previously [6] . Details are shown in Supplemental Figure S1 , and primer sequences are shown in Supplemental Table S1 .
We used the PCR screen to study 43 first-generation (F 1 ) and 25 second-generation (F 2 ) descendants of the bull YN51 sample, in which the deletion was first identified. Four F 1 animals were found to carry the MIMT1 Del/WT gene, all were females with normal reproductive capability. One young F 2 bull was also identified as a MIMT1 Del/WT carrier. Once he attains reproductive maturity he will be used to produce fetuses for further research.
MIMT1
Del/WT Fetuses and Fetal Cotyledon Tissue
To identify the primary cause of fetal growth reduction and stillbirth, we investigated gene expression and DNA methylation levels in animals before any pathological changes were apparent. Studies were performed with brain and cotyledon tissues from 22 fetuses from dams slaughtered between days 41 and 157 of pregnancy (normal gestation in this Bos taurus breed is 280 6 10 days). At this stage, MIMT1
Del/WT and MIMT1 WT/WT fetuses showed no evident differences in fetal size or development. The histology of both the cotyledon (placenta pars fetalis) and caruncula (placenta pars maternalis) appeared normal for all fetuses examined (Supplemental Fig. S2 ).
MIMT1 Deletion Results in Altered Global DNA Methylation Levels
We detected a mean 31.5 6 6.82% global DNA methylation in cotyledon and 71.2 6 4.43 % in fetal brain samples.
MIMT1
Del/WT cotyledons showed significantly greater global DNA methylation (35.08 6 6.18 %) than MIMT1 WT/WT cotyledons (27.2 6 4.91 %; P ¼ 0.003) (Fig. 1) . We found an age-dependent but statistically nonsignificant decrease of DNA methylation in all samples. However, all MIMT1 WT/Del samples showed a higer level of DNA methylation than MIMT1 WT/WT samples of similar age. No differences in fetal brain DNA methylation were detected.
MIMT1 Deletion Affects Gene Expression Levels in Fetal Placenta
To identify transcriptome differences between MIMT1 Del/WT and MIMT1 WT/WT fetal placentas, samples of fetal cotyledon were analyzed using SurePrint G3 custom gene expression arrays (Agilent ). Ten microarrays (six MIMT1 Del/WT and four MIMT1 WT/WT ) were hybridized and evaluated. After data processing and normalization, microarray data sets were initially analyzed with correlation heat maps to cluster the WT/WT age-matched samples. More than 430 probes showed differential expression with nominal P values of , 0.01 (P , 0.00001-0.00999), but no significant probes were obtained after correction for multiple testing. To further explore the data set, we selected those genes showing most marked difference in expression on the basis of fold differences and nominal P values. A total of 140 genes with increased mRNA levels in MIMT1 Del/WT and 108 with reduced levels of MIMT1 Del/WT (Supplemental Table S2 ) were subjected to hierarchical cluster analysis. The heat map shown in Figure 2 reveals that MIMT1 WT/WT samples formed a relatively homogeneous group with similar expression patterns. The MIM-T1 Del/WT samples were more heterogeneous, with sample C9 being most similar to the control samples.
Of the genes with at least two-fold differential expression and a P value ,0.01, we selected for detailed analysis 17 genes whose known functions were likely to affect prenatal development. Up-regulated genes were IGF2, DLK1, MEST, H19, NOS3, IL1RN, IL4R, ZDHHC22, SMOC2, and NPSR1; and down-regulated genes were PEG3, APEG3, AST1, GRID1, PLG, IGF1, and AST1. Among these, the IL1RN, IL4R, ZDHHC22, and SMOC2 genes showed .5-fold increased expression in MIMT1 Del/WT cotyledons, and the greatest decrease in expression was seen in AST1 (.5-fold). High expression of NPSR1 in four of the six MIMT1 Del/WT cotyledon samples (C1, C3, C5, C6) was especially notable because this gene is not normally expressed in placenta, a finding confirmed by qRT-PCR analysis of control samples (Fig. 3) . Ten genes were investigated by qRT-PCR analysis. These genes were selected on the basis of marked differential expression (NPSR1, IL1RN, SMOC2) or known importance in prenatal development (IGF2, DLK1, MEST, AST1, PEG3, APEG3, H19). qRT-PCR was performed with 11 MIMT1 Del/WT and 11 MIMT1
WT/WT cotyledon samples, including those used for microarray analysis. In each case, qRT-PCR analysis showed differences in expression very similar to those detected by microarray (Table 1) . Paternal MIMT1 Del/WT transmission leads to 85% mortality in offspring. Results of the hierarchical cluster analysis provided intriguing hints as to why some MIMT1 Del/WT calves survive. As Figure 2 shows, the gene expression pattern of fetus C12 and, more strikingly, fetus C9 bear a closer resemblance to control samples than do the other MIMT1 Del/WT fetuses. The one clear qualitative difference between these and other MIMT1 Del/WT samples is the lack of aberrant NPSR1 expression. Excluding C9 and C12 from the microarray data comparison revealed more marked differences in gene expression, with IL1RN, SMOC2, and ZDHHC22 showing .10-fold higher expression in MIMT1 Del/WT C1, C3, C5, and C6 fetuses than in MIMT1
WT/WT fetuses (Supplemental Table S2 ). The differentially expressed genes we have identified can be grouped into the following categories: 1) imprinted genes already known to affect mammalian prenatal development (IGF2, DLK1, MEST, AST1, PEG3, APEG3, H19); 2) genes associated with fetal/placental blood circulation and proinflammatory immune response in the fetus (NPSR1, IL1RN, NOS3, IL4R); and 3) genes whose role in fetal development is unknown (SMOC2, ZDHHC22).
Expression Analysis of NPSR1 Isoform A
The NPSR1 gene expresses two mRNA isoforms, A and B, which arise from alternative 3 0 exon use [15] . In humans, isoform A is expressed in specific regions of the brain [16] ,
FIG. 2. Results of hierarchical cluster analysis of MIMT1
Del/WT and MIMT1 WT/WT cotyledon transcripts. Genes were sorted on the basis of a score calculated from the fold change in expression and statistical P value (where score ¼ log2 (fold change þ 2) 3 log10 [P value]). Relative expression levels of 248 genes with the highest scores were used for cluster analysis of genes and samples. The names of differentially expressed genes are listed in Supplemental Table S2 .
FIG. 3. RT-PCR analysis of NPSR1A expression in MIMT1
Del/WT cotyledons.
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skin, lung, and gastrointestinal tract [17] , and B is expressed in bronchi of asthmatic patients [18] . We analyzed NPSR1A expression by conventional RT-PCR in cotyledon, brain, lung, kidney, heart, liver, and muscle samples of MIMT1 Del/WT and MIMT1
WT/WT fetuses and in the corresponding maternal caruncles for each fetus. Strong NPSR1A mRNA expression was detected in cotyledons of 7 of 11 MIMT1 Del/WT fetuses ( Table 2 ; Fig. 3 ). NPSR1A mRNA expression was not detected in other fetal tissues nor in the maternal caruncles (Supplemental Fig. S3 ). NPSR1 protein expression, observed in three fetuses showing NPSR1A mRNA expression (C5, C6, C15) and in one fetus that lacked NPSR1A mRNA expression, was further analyzed by Western blotting (Fig. 4) . Analysis with anti-NPSR1 antibody revealed a ;50-kDa species, similar to that detected in human tissues [17] , in cotyledon samples from fetuses C5, C6, and C15. This was not detected in cotyledon C14.
DISCUSSION
Normal placental function is clearly critical for fetal health. It is well known that altered placental gene expression and subsequent function results in alteration of fetal growth [19] . Here we describe genome-wide alterations to DNA methylation and marked differences in the expression of particular genes in cotyledons as a consequence of a deletion in a single noncoding gene, MIMT1. Our results suggest a hitherto unknown regulatory function for this gene.
The level of DNA methylation in normal bovine cotyledon is similar to that in human placenta [20, 21] . MIMT1 Del/WT animals showed increased DNA methylation, which accords with other findings showing that aberrant placental DNA methylation affects fetal growth and development. The 7% difference in global DNA methylation between MIMT1 Del/WT and MIMT1 WT/WT represents a significant increase and is most likely due to DNA methylation changes in a relatively small set of genes, most probably those few hundred identified by our gene expression analysis. Particular patterns of DNA methylation in human placenta are associated with intrauterine growth restriction (IUGR) of infants [22] . Abnormal DNA methylation can also lead to abnormal placental morphology and adverse birth outcomes [23] . Because the increased methylation in MIMT1 Del/WT cotyledons was detected before any evident change in growth or other pathology, it is more likely to be a cause rather than a consequence of growth retardation. Aberrant DNA methylation of particular genes, including those found to be differentially expressed in our study, has also been associated with prenatal growth restriction. Diplas et al. [24] found differential methylation of several imprinted genes in the placenta of IUGR infants, and Tabano et al. [25] showed that aberrant CpG methylation at the imprinting control region of the IGF2/H19 domain in placenta is associated with infant growth restriction. Aberrant methylation of PEG3 has been observed in cases involving stillbirths and aborted fetuses in humans [26] and aborted cloned bovine embryos [27] .
The MIMT1 Del/WT genotype induces not only widespread alternations in DNA methylation but also aberrant expression of the placental transcriptome. It is particularly interesting that three (IL1RN, IL4R , and NOS3) of the six genes showing the most marked increase in expression in MIMT1 Del/WT cotyledons are associated with placental blood circulation and inflammation. These may provide an early indication of the perturbations that threaten most MIMT1 Del/WT fetuses later in pregnancy and signpost mechanisms responsible for fetal growth retardation.
The interleukin 1 (IL1) receptor antagonist (IL1RN) gene is a member of the interleukin 1 cytokine family and modulates a variety of inflammatory responses. Several studies have also demonstrated the important role of proinflammatory cytokines in pregnancy outcome. Romero et al. [28] determined that a systematic fetal inflammatory response, measured as elevated fetal plasma IL6, was an independent risk factor of severe neonatal morbidity. Moreover, Gerber et al. [29] found a significant association between an IL1RN intron 2 tandem repeat polymorphism and spontaneous stillbirths, suggesting that IL1RN increases susceptibility to fetal death by inducing a [30] . Clark et al. [31] found that genetic variations in the extracellular domain of IL4R may contribute to the neurodevelopmental delay in 2-year-old children from pregnancies with high risk for preterm birth. The nitric oxide synthase 3 (NOS3, endothelial NOS) gene plays a role in many female reproduction processes such as ovulation, uterine quiescence, and disorders such as pregnancy-induced hypertension and pre-eclampsia [32] . Nos3-knockout mice show reduced fetal growth and increased late gestation mortality [33] and deliver underweight pups [34] . We found more than two-fold increased expression of NOS3 in MIMT1 Del/WT cotyledons, a finding that corresponds with increased NOS3 expression in placentas of IUGR patients [35] .
Because of the role of imprinting in the stillbirth phenotype, we examined the effect of the deletion not only on PEG3 expression but also on that of other imprinted genes. The twofold increase in both IGF2 and H19 gene expression is noteworthy and suggests loss of H19 imprinting. In mice, paternally expressed IGF2 stimulates placental growth, whereas maternally expressed H19 reduces placental weight [36] . Increased placental expression of both genes was observed when H19 lost imprinting and was expressed from both parental alleles [37] . We also found approximately two-fold down-regulation of PEG3 and APEG3, which accords with our previous study [6] . These data suggest that MIMT1 interacts with and affects the expression of a network of imprinted genes including IGF2, H19, and PEG3. Changes of PEG3 expression have also been observed in diabetic mice [38] and IUGR human placentas [24] .
SMOC1 and ZDHHC22 have not previously been associated with placental dysfunction or stillbirth. SMOC1 belongs to the SPARC matricellular protein family that modulates cell-matrix interaction by binding to many cell surface receptors, growth factors, and cytokines. It has been suggested that SMOC1 modulates BMP signaling [39] and is associated with microphthalmia in newborns [40] . Little is known about the function of ZDHHC22, although the product of the closely associated ZDHHC23 gene is involved in regulating nitric oxide synthase in rat neurons [41] .
The clearest marker of pregnancy perturbation we observed was aberrant placental expression of NPSR1 in a high proportion of MIMT1 Del/WT animals. Neuropeptide S receptor 1, also know as vasopressin receptor-related receptor 1, is a 7-transmembrane G protein-coupled receptor that induces intracellular signaling by mobilization of calcium, increasing cAMP and activation of the mitogen-activated protein kinase pathway [42] . NPSR1 expresses two full-length mRNA isoforms, A and B, using alternative 3 0 exons [15] . In humans, isoform A is expressed in specific regions of the brain [16] , skin, lung, and gastrointestinal tract [17] , and B is expressed in bronchi of asthmatic patients [18] . NPSR1 knockout mice have revealed an essential role for NPSR1A in stress-induced corticosterone release [43] . Marques et al. [44] found increased NPSR1A expression in the hypothalamus of BPH/2J hypertensive mice. It has also been found that in vitro activation of NPSR1A overexpressing cell lines with neuropeptide S results in considerable growth inhibition [17] .
We found that 7 of 11 of MIMT1 Del/WT fetuses abnormally expressed NPSR1A in placental cotyledon. The similarity between this proportion and the semilethal mortality rate suggests that abnormal NPSR1A expression may be linked to death or survival of MIMT1
Del/WT fetuses. However, this has yet to be confirmed.
How MIMT1 and dysregulation of the PEG3 domain lead to the observed changes in gene expression, especially that of NPSR1A, is the subject of future study, but our findings clearly indicate that altered placental function plays a role in the stillbirth phenomenon, providing a useful avenue to investigate and identify the underlying pathological mechanisms. The simple PCR test across the deletion breakpoints enables easy identification of affects in MIMT1 Del/WT animals. Our study shows that MIMT1 is part of a complex network of gene regulation and hints at an as-yet-undefined function of NPSR1. Whether abnormal placental NPSR1A expression also plays a role in perturbations of human pregnancy is an intriguing possibility.
